Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001868923 | SCV002220186 | pathogenic | Fanconi anemia | 2021-04-16 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Glu1196*) in the FANCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCA are known to be pathogenic (PMID: 19367192). This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with Fanconi anemia (PMID: 29247345). ClinVar contains an entry for this variant (Variation ID: 592052). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003465654 | SCV004196628 | likely pathogenic | Fanconi anemia complementation group A | 2022-06-19 | criteria provided, single submitter | clinical testing | |
Gharavi Laboratory, |
RCV000723238 | SCV000854369 | uncertain significance | not provided | 2018-09-16 | no assertion criteria provided | research |